Stockholders' Equity (Tables)

12 Months Ended

Sep. 30, 2017

Schedule Of Stock Compensation Expense [Table Text Block]

Stock compensation expense is recorded in general and administrative operating expenses and is presented below for the years ended September 30, 2017 and 2016:

	2017		2016
Stock Grants	$	241,000	$	322,000
Restricted Stock Grants		52,000		45,000
Option Grants		50,000		42,000
Employee Stock Purchase Plan		3,000		3,000
Subsidiary Stock Grants		-		210,000
Subsidiary Option Grants		110,000		76,000
Total	$	456,000	$	698,000

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

A summary of restricted stock activity for the year ended September 30, 2017 and 2016 is presented below:

Restricted Stock Activity for the Year ended September 30, 2017	Shares			Weighted-Average Grant-Date Fair Value
Nonvested at September 30, 2016		100,000		$	1.73
Granted		-			-
Vested		(30,000	)	$	1.73
Cancelled		-			-
Nonvested and expected to vest at September 30, 2017		70,000		$	1.73

Restricted Stock Activity for the Year ended September 30, 2016	Shares			Weighted-Average Grant-Date Fair Value
Nonvested at September 30, 2015		27,000		$	1.04
Granted		100,000		$	1.73
Vested		(27,000	)	$	1.04
Cancelled		-			-
Nonvested and expected to vest at September 30, 2016		100,000		$	1.73

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

Stock options outstanding at September 30, 2017 are described as follows:

Outstanding Stock Options at September 30, 2017
Range of Exercise Prices		Options Outstanding		Weighted Average Contractual Life (years)		Weighted Average Exercise Price		Options Exercisable		Weighted Average Exercise Price
$	1.80 - 1.99		131,834		1.79	$	1.81		131,834	$	1.81
	2.00 - 2.33		64,935		1.34		2.33		64,935		2.33
$	1.80 - 2.33		196,769		1.64	$	1.98		196,769	$	1.98

Stock Option Grants [Member]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

A summary of stock option activity for the years ended September 30, 2017 and 2016 is presented below:

					Weighted Average
			Weighted Average		Remaining
	Options		Exercise Price per		Contractual Term
	Outstanding		Share ($)		(in Years)
Balance at September 30, 2015		58,212		2.28		1.96
Outstanding and exercisable at September 30, 2015		58,212		2.28		1.96
Granted		64,935		2.33
Exercised		-		-
Cancelled		-		-
Balance at September 30, 2016		123,147		2.30		1.69
Outstanding and exercisable at September 30, 2016		123,147		2.30		1.69
Granted		95,602		1.80
Exercised		-		-
Cancelled		(21,980)		3.03
Balance at September 30, 2017		196,769		1.98		1.64
Outstanding and exercisable at September 30, 2017		196,769		1.98		1.64

Subsidiary Option Grants [Member]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

A summary of Xcede stock option activity for the years ended September 30, 2017 and 2016 is presented below:

					Weighted Average
			Weighted Average		Remaining
	Options		Exercise Price per		Contractual Term
	Outstanding		Share ($)		(in Years)
Balance, expected to vest, at September 30, 2015		780,258		1.00		8.85
Outstanding and exercisable at September 30, 2015		180,293		1.00		8.50
Granted		148,419		1.00
Exercised		-		-
Cancelled		(315,024)		1.00
Balance, expected to vest, at September 30, 2016		613,653		1.00		8.35
Outstanding and exercisable at September 30, 2016		320,586		1.00		8.01
Granted		810,500		1.00
Exercised		-		-
Cancelled		(48,197)		1.00
Balance, expected to vest, at September 30, 2017		1,375,956		1.00		8.70
Outstanding and exercisable at September 30, 2017		923,617		1.00		8.30